
|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
- Volume 5
- Issue 8 Suppl
Participating Faculty
Advertisement
Articles in this issue
over 26 years ago
Introductionover 26 years ago
Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritisover 26 years ago
Methotrexate Therapy in the Year 2000: Outstanding Questionsover 26 years ago
State-of-the-Art Combination Therapy in 1999over 26 years ago
Selected Abstractsover 26 years ago
CME Quizover 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
2
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
3
Physical Activity, Vaccination May Protect Against Long COVID
4
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
5